KKR, Hildred and EQT Life Sciences invest in diagnostics company Onvaro
KKR•KKR-managed funds, Hildred and EQT Life Sciences are investing new capital in Onvaro to support growth. Its binx io molecular point-of-care platform has more than 1,000 installed instruments.
1. Investment and expansion
KKR-managed funds, Hildred and EQT Life Sciences are investing new capital in Onvaro, formed through the combination of Sapphiros and binx health. The investment will support commercial expansion and development of decentralized testing products; Onvaro's commercial portfolio centers on the binx io molecular point-of-care platform, with more than 1,000 installed instruments.
